1.Cost-effectiveness Analysis of Therapeutic schemes for Peptic Ulcer With Helicobacteria Pylori
China Pharmacy 1991;0(05):-
OBJECTIVE:To evaluate the economic effectiveness of different pharmacotherapeutic schemes for the same disease Three therapeutic schemes(including A,B and C schemes)for peptic ulcer with Helicobacteria pylori were compared METHODS:The schemes were evaluated with pharmacoeconomic cost-effectiveness analysis RESULTS:The results showed that B was the best scheme from either cost-effectiveness analysis(C/E)or increasing costeffectiveness analysis(?C/?E) CONCLUSION:Pharmacoeconomics is very important in optimizing therapeutic scheme,guiding rational drug use and in_creasing economic effectiveness
2.Cost- effectiveness Analysis of Therapeutic schemes for Peptic Ulcer With Helicobacteria Pylori
Qinyun ZHENG ; Yanle QI ; Guanyang LIN
China Pharmacy 2001;12(5):282-283
OBJECTIVE: To evaluate the economic effectiveness of different pharmacotherapeutic schemes for the same disease Three therapeutic schemes( including A, B and C schemes) for peptic ulcer with Helicobacteria pylori were compared METHODS: The schemes were evaluated with pharmacoeconomic cost- effectiveness analysis RESULTS: The results showed that B was the best scheme from either cost- effectiveness analysis( C/E) or increasing costeffectiveness analysis( Δ C/Δ E) CONCLUSION: Pharmacoeconomics is very important in optimizing therapeutic scheme, guiding rational drug use and in_ creasing economic effectiveness